FDA Authorizes COVID Antibody Treatment as Preventive After Exposure – NBC 5 Dallas-Fort Worth

People at significant risk of developing severe COVID-19, including millions of Americans with compromised immune systems, now have the option to receive preventive treatment with monoclonal antibodies if they have been exposed to the coronavirus or are at risk.

The Food and Drug Administration’s action on Friday brings hope to the estimated 3% of Americans with compromised immune systems, including those with autoimmune diseases, HIV patients, cancer patients, and organ transplant recipients who may still be susceptible to COVID even after being fully vaccinated.

This is the first time an injectable coronavirus antibody treatment has been approved for the prevention of COVID after someone was exposed to the virus.

Read the full story on NBCNews.com.

[ad_1]